HOME › 
HEALTH

ASCO 2016: Dr. Susan O’Brien Where She Discusses Frontline Data on Acalabrutinib in CLL( Chronic Lymphocytic Leukemia)

By Bkoffman
We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize that we have quite a few interviews from the ASCO and EHA meetings that have not yet been posted, so we’ll be posting twice a week until they are all out the door on the CLL Society's website. 
If you have not yet participated in our Reader Poll to give us feedback about how we’re doing and what topics you would like to see covered in the future, please take 2 minutes and do so if you have time. You can access it here. https://q32016ask.questionpro.com/
We just posted an interview from ASCO 2016 with Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib, a promising second-generation BTK inhibitor. You can access my article, the abstract and our interview here. http://cllsociety.org/2016/10/asco-2016-acalabrutinib-frontline-cll
NEW Patient & Caregiver Support MeetingsTuesday, October 18that 6:30 PM at the Levine Cancer Institute in Charlotte, NC – the first meeting of a new CLL Patient & Caregiver Support and Education Group. Patients and family caregivers are welcome. Find out more about dates and registration here. http://cllsociety.org/docs/CLL%20Patient%20Caregiver%20Support%20Group%20Levine%20Cancer%20Center.pdf
Tuesday, November 1stat 6:30 PM at the Moffitt McKinley Outpatient Center in Tampa, FL – the first meeting of a new CLL Patient & Caregiver Support and Education Group. Patients and family caregivers are welcome. You can find more information here! http://cllsociety.org/docs/Tampa%20Patient%20Support%20Group%20Flyer.pdf
If you’re aware of other CLL Patient Support Group meetings, let us know and we’ll post them.

Thanks.10/6/16

http://cllsociety.orgIf you want a personal response, or just want to stay in touch, please email me at bkoffmanMD@gmail.com. I have no other way of contacting. Thanks. Stay strong. After all, we are all in this together. And please visit our website: http://cllsociety.org for the latest news and information.